Monopar Therapeutics (MNPR) EPS (Basic) (2017 - 2025)
Monopar Therapeutics (MNPR) reported EPS (Basic) of -$0.6 for Q3 2025, down 42.99% on a YoY basis from -$1.05 in Q3 2024, and down 62.72% sequentially from -$0.37 in Q2 2025.
Monopar Therapeutics (MNPR) EPS (Basic) (2017 - 2025) Analysis & Trends
Monopar Therapeutics (MNPR) has 9 years of EPS (Basic) data on file, last reported at -$0.6 in Q3 2025.
- For the quarter ending Q3 2025, EPS (Basic) fell 42.99% year-over-year to -$0.6; the trailing twelve-month figure through Dec 2025 stood at -$1.36 (down 3.69% YoY), and the FY2025 full-year result was -$1.85, up 54.72% from the prior year.
- EPS (Basic) declined to -$0.6 in Q3 2025, from -$0.37 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.37 in Q2 2025 to a low of -$5.28 in Q4 2022.
- A 5-year average of -$1.21 and a median of -$0.83 in 2021 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) sank 45.75% in 2021 and soared 43.9% in 2024, its largest moves.
- Tracing MNPR's EPS (Basic) over 5 years: stood at -$4.17 in 2021, then declined by 26.53% to -$5.28 in 2022, then surged by 86.89% to -$0.69 in 2023, then surged by 39.42% to -$0.42 in 2024, then tumbled by 42.99% to -$0.6 in 2025.
- Business Quant data shows MNPR's EPS (Basic) at -$0.6 in Q3 2025, -$0.37 in Q2 2025, and -$0.46 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.60 |
| Jun 30, 2025 | -0.37 |
| Mar 31, 2025 | -0.46 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -0.51 |
| Mar 31, 2024 | -0.53 |
| Sep 30, 2023 | -0.69 |
| Jun 30, 2023 | -0.87 |
| Mar 31, 2023 | -0.95 |
| Dec 31, 2022 | -5.28 |
| Sep 30, 2022 | -0.95 |
| Jun 30, 2022 | -1.13 |
| Mar 31, 2022 | -0.98 |
| Dec 31, 2021 | -4.17 |
| Sep 30, 2021 | -0.98 |
| Jun 30, 2021 | -0.83 |
| Mar 31, 2021 | -0.78 |
| Dec 31, 2020 | -3.41 |
| Sep 30, 2020 | -0.74 |
| Jun 30, 2020 | -0.69 |